These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9414484)

  • 21. Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells.
    Sun H; Zhou X; Wu B
    Xenobiotica; 2015; 45(11):945-53. PubMed ID: 26068529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes.
    Williams JA; Ring BJ; Cantrell VE; Campanale K; Jones DR; Hall SD; Wrighton SA
    Drug Metab Dispos; 2002 Nov; 30(11):1266-73. PubMed ID: 12386134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of morphine glucuronidation in the liver microsomes of rats and humans by monoterpenoid alcohols.
    Ishii Y; Iida N; Miyauchi Y; Mackenzie PI; Yamada H
    Biol Pharm Bull; 2012; 35(10):1811-7. PubMed ID: 22878261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of inhibition capability of scutellarein and scutellarin towards important liver UDP-glucuronosyltransferase (UGT) isoforms.
    Ma GY; Cao YF; Hu CM; Fang ZZ; Sun XY; Hong M; Zhu ZT
    Phytother Res; 2014 Mar; 28(3):382-6. PubMed ID: 23620377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
    Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
    Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilirubin glucuronidation by intact Gunn rat fibroblasts expressing bilirubin UDP-glucuronosyltransferase.
    Seppen J; Tada K; Hellwig S; Bakker CT; Prasad VR; Roy Chowdhury N; Roy Chowdhury J; Bosma PJ; Oude Elferink RP
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):477-83. PubMed ID: 8670060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro N-glucuronidation of SB 47436 (BMS 186295), a new AT1 nonpeptide angiotensin II receptor antagonist, by rat, monkey and human hepatic microsomal fractions.
    Perrier L; Bourrié M; Marti E; Tronquet C; Massé D; Berger Y; Magdalou J; Fabre G
    J Pharmacol Exp Ther; 1994 Oct; 271(1):91-9. PubMed ID: 7965761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive mode.
    Takeda S; Kitajima Y; Ishii Y; Nishimura Y; Mackenzie PI; Oguri K; Yamada H
    Drug Metab Dispos; 2006 Aug; 34(8):1277-82. PubMed ID: 16679387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation.
    Senafi SB; Clarke DJ; Burchell B
    Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):233-40. PubMed ID: 7945246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-inhibition relationship of podophyllotoxin (PT) analogues towards UDP-glucuronosyltransferase (UGT) isoforms.
    Qi JQ; Cao YF; Sun XY; Hong M; Fang ZZ; Meng DL; Sun DX
    Pharmazie; 2015 Apr; 70(4):239-43. PubMed ID: 26012253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent inhibitors of the human UDP-glucuronosyltransferase 2B7 derived from the sesquiterpenoid alcohol longifolol.
    Bichlmaier I; Kurkela M; Joshi T; Siiskonen A; Rüffer T; Lang H; Finel M; Yli-Kauhaluoma J
    ChemMedChem; 2007 Jun; 2(6):881-9. PubMed ID: 17479992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3'-azido-3'-deoxythymidine: characterization of the enzyme in human and rat liver microsomes.
    Haumont M; Magdalou J; Lafaurie C; Ziegler JM; Siest G; Colin JN
    Arch Biochem Biophys; 1990 Sep; 281(2):264-70. PubMed ID: 2118332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of oral administration of ursodeoxycholic acid on rat hepatic and intestinal UDP-glucuronosyltransferase.
    Sánchez Pozzi EJ; Catania VA; Luquita MG; Roma MG; Rodríguez Garay EA; Mottino AD
    Can J Physiol Pharmacol; 1994 Nov; 72(11):1265-71. PubMed ID: 7767865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor.
    Kazmi F; Yerino P; Barbara JE; Parkinson A
    Drug Metab Dispos; 2015 Sep; 43(9):1294-302. PubMed ID: 26135009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.
    Tsoutsikos P; Miners JO; Stapleton A; Thomas A; Sallustio BC; Knights KM
    Biochem Pharmacol; 2004 Jan; 67(1):191-9. PubMed ID: 14667942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acyl-CoA binding and acylation of UDP-glucuronosyltransferase isoforms of rat liver: their effect on enzyme activity.
    Yamashita A; Watanabe M; Tonegawa T; Sugiura T; Waku K
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):301-8. PubMed ID: 7492328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substrates and products of purified rat liver bilirubin UDP-glucuronosyltransferase.
    Chowdhury NR; Arias IM; Lederstein M; Chowdhury JR
    Hepatology; 1986; 6(1):123-8. PubMed ID: 3080359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triclosan as a substrate and inhibitor of 3'-phosphoadenosine 5'-phosphosulfate-sulfotransferase and UDP-glucuronosyl transferase in human liver fractions.
    Wang LQ; Falany CN; James MO
    Drug Metab Dispos; 2004 Oct; 32(10):1162-9. PubMed ID: 15269185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
    Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J
    Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.